Evercore ISI analyst Elizabeth Anderson CFA has maintained their bullish stance on HNGE stock, giving a Buy rating yesterday.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Elizabeth Anderson CFA has given his Buy rating due to a combination of factors including confidence in Hinge Health’s competitive positioning and growth trajectory. She emphasizes that Hinge’s win rates have climbed to roughly 80% in 2025 and early feedback from the 2026 selling cycle signals further momentum, supporting her view that revenue can grow about 25% next year while operating leverage expands.
She also underscores that Sword Health’s purchase of Kaia Health is unlikely to threaten Hinge because pricing differentials have remained stable, industry pricing pressure appears limited, and the digital musculoskeletal market still offers ample white space for multiple scaled players. Anderson anticipates the upcoming February 10 earnings release and 2026 outlook to act as a positive catalyst, reinforcing her $65 price target and Buy stance.
In another report released yesterday, TipRanks – PerPlexity also upgraded the stock to a Buy with a $48.00 price target.